144 related articles for article (PubMed ID: 29417422)
1. Unmet Patient Need in Statin Intolerance: the Clinical Characteristics and Management.
Harrison TN; Hsu JY; Rosenson RS; Levitan EB; Muntner P; Cheetham TC; Wei R; Scott RD; Reynolds K
Cardiovasc Drugs Ther; 2018 Feb; 32(1):29-36. PubMed ID: 29417422
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
[TBL] [Abstract][Full Text] [Related]
3. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
Harrison TN; Scott RD; Cheetham TC; Chang SC; Hsu JY; Wei R; Ling Grant DS; Boklage SH; Romo-LeTourneau V; Reynolds K
Cardiovasc Drugs Ther; 2018 Aug; 32(4):397-404. PubMed ID: 30062465
[TBL] [Abstract][Full Text] [Related]
4. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.
Cho L; Dent R; Stroes ESG; Stein EA; Sullivan D; Ruzza A; Flower A; Somaratne R; Rosenson RS
Cardiovasc Drugs Ther; 2018 Aug; 32(4):365-372. PubMed ID: 30073585
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES Study.
Bair TL; May HT; Knowlton KU; Anderson JL; Lappe DL; Muhlestein JB
J Cardiovasc Pharmacol; 2020 May; 75(5):426-431. PubMed ID: 32079856
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.
Hajahmadi Pourrafsanjani M; Khayati Shal E; Khezrpour S
High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):37-43. PubMed ID: 30684247
[TBL] [Abstract][Full Text] [Related]
8. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
[TBL] [Abstract][Full Text] [Related]
10. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
11. Statin Intolerance.
Brown AS; Watson KE
Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
[TBL] [Abstract][Full Text] [Related]
12. Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy.
Hyun MH; Lee Y; Choi BG; Na JO; Choi CU; Kim JW; Kim EJ; Rha SW; Park CG; Lee E; Seo HS
Cardiovasc Ther; 2019; 2019():3824823. PubMed ID: 31885691
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.
Hai JJ; Wong YK; Wong CK; Un KC; Chan PH; Siu CW; Yiu KH; Lau CP; Tse HF
BMC Cardiovasc Disord; 2019 Jul; 19(1):168. PubMed ID: 31307391
[TBL] [Abstract][Full Text] [Related]
14. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
15. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
Thompson PD
Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
[No Abstract] [Full Text] [Related]
16. Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study.
Schleyer T; Hui S; Wang J; Zhang Z; Knapp K; Baker J; Chase M; Boggs R; Simpson RJ
J Manag Care Spec Pharm; 2019 May; 25(5):544-554. PubMed ID: 31039062
[TBL] [Abstract][Full Text] [Related]
17. Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.
Simpson RJ; Tunceli K; Ramey DR; Neff DR; Kern DM; Hsieh HM; Wertz DA; Stephenson JJ; Marrett E; Tomassini JE; Jacobson TA
J Clin Lipidol; 2013; 7(5):399-407. PubMed ID: 24079280
[TBL] [Abstract][Full Text] [Related]
18. Atheroma progression in hyporesponders to statin therapy.
Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
[TBL] [Abstract][Full Text] [Related]
19. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage.
Chang JJ; Katsanos AH; Khorchid Y; Dillard K; Kerro A; Burgess LG; Goyal N; Alexandrov AW; Alexandrov AV; Tsivgoulis G
Atherosclerosis; 2018 Feb; 269():14-20. PubMed ID: 29253643
[TBL] [Abstract][Full Text] [Related]
20. Serum Low-Density Lipoprotein Cholesterol Level After Endovascular Therapy in Patients With Claudication.
Tomoi Y; Yamaji K; Soga Y; Hiramori S; Ando K
J Endovasc Ther; 2019 Jun; 26(3):402-410. PubMed ID: 30873910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]